Unexplained Infertility: Treatment Strategy for Unexplained Infertility

  • Chapter
  • First Online:
Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage
  • 623 Accesses

Abstract

The candidate causes of unexplained infertility are (1) oviduct dysfunction with tubal patency, (2) fertilization failure and (3) implantation failure without an organic lesion. At any rate, undetectable causes of infertility inhibit the processes of sperm-egg encounter or implantation. Thus, patients with unexplained infertility cannot benefit from general infertility treatment, including timed intercourse or intrauterine insemination. Assisted reproductive technology including in vitro fertilization can overcome tubal dysfunction and fertilization failure, but not recurrent implantation failure (RIF). As regards RIF, hysteroscopy and blood tests for immunological abnormality and recurrent miscarriage should be performed as clinically practicable implantation testing. The treatment of RIF is the remedy of detected causes. If there is no cause of implantation failure, treatment approaches include endometrial injury during luteal phase, systemic single-dose G-CSF injection at embryo transfer, a vitrified-warmed single blastocyst transfer with assisted hatching and hyaluronan-enriched medium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gunn DD, Bates GW. Evidence-based approach to unexplained infertility: a systematic review. Fertil Steril. 2016;105:1566–1574.e1.

    Article  PubMed  Google Scholar 

  2. Chaffkin LM, Nulsen JC, Luciano AA, Metzger DA. A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin (hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone**presented in part at the 45th annual meeting of the American Fertility Society, San Francisco, California, November 13 to 16, 1989. Fertil Steril. 1991;55:252–7.

    Article  PubMed  CAS  Google Scholar 

  3. Tanahatoe SJ, Hompes PGA, Lambalk CB. Investigation of the infertile couple – should diagnostic laparoscopy be performed in the infertility work up programme in patients undergoing intrauterine insemination? Hum Reprod. 2003;18:8–11.

    Article  PubMed  Google Scholar 

  4. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril. 2001;76:1–10.

    Article  PubMed  CAS  Google Scholar 

  5. Marcoux S, Maheux R, Berube S, Langevin M, Graves G, Wrixon W, et al. Laparoscopic surgery in infertile, women with minimal or mild endometriosis. N Engl J Med. 1997;337:217–22.

    Article  PubMed  CAS  Google Scholar 

  6. Kashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K. Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update. 2010;16:690–703.

    Article  PubMed  CAS  Google Scholar 

  7. Flaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fertilization after intracytoplasmic sperm injection. Hum Reprod. 1998;13:155–64.

    Article  PubMed  Google Scholar 

  8. Yamaguchi T, Ito M, Kuroda K, Takeda S, Tanaka A. The establishment of appropriate methods for egg-activation by human PLCZ1 RNA injection into human oocyte. Cell Calcium. 2017;65:22–30.

    Article  PubMed  CAS  Google Scholar 

  9. Scott RT. Introduction: Subchromosomal abnormalities in preimplantation embryonic aneuploidy screening. Fertil Steril. 2017;107:4–5.

    Article  PubMed  Google Scholar 

  10. Treff NR, Franasiak JM. Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations. Fertil Steril. 2017;107:27–31.

    Article  PubMed  Google Scholar 

  11. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by ‘recurrent implantation failure’? A systematic review and opinion. Reprod Biomed Online. 2014;28:409–23.

    Article  PubMed  Google Scholar 

  12. Irahara M, Kuwahara A, Iwasa T, Ishikawa T, Ishihara O, Kugu K, et al. Assisted reproductive technology in Japan: a summary report of 1992–2014 by the Ethics Committee, Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2017;16:126–32.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Altmae S, Reimand J, Hovatta O, Zhang P, Kere J, Laisk T, et al. Research resource: interactome of human embryo implantation: identification of gene expression pathways, regulation, and integrated regulatory networks. Mol Endocrinol. 2012;26:203–17.

    Article  PubMed  CAS  Google Scholar 

  14. Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95:50–60.

    Article  PubMed  CAS  Google Scholar 

  15. Guffanti E, Kittur N, Brodt ZN, Polotsky AJ, Kuokkanen SM, Heller DS, et al. Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci. 2008;121:2037–45.

    Article  PubMed  CAS  Google Scholar 

  16. Mekinian A, Cohen J, Alijotas-Reig J, Carbillon L, Nicaise-Roland P, Kayem G, et al. Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation? Am J Reprod Immunol. 2016;76:8–28.

    Article  PubMed  CAS  Google Scholar 

  17. Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril. 2001;76:201–2.

    Article  PubMed  CAS  Google Scholar 

  18. Azem F, Many A, Ben Ami I, Yovel I, Amit A, Lessing JB, et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368–70.

    Article  PubMed  Google Scholar 

  19. Friedler S, Schachter M, Strassburger D, Esther K, Ron El R, Raziel A. A randomized clinical trial comparing recombinant hyaluronan/recombinant albumin versus human tubal fluid for cleavage stage embryo transfer in patients with multiple IVF-embryo transfer failure. Hum Reprod. 2007;22:2444–8.

    Article  PubMed  CAS  Google Scholar 

  20. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update. 2011;17:438–53.

    Article  PubMed  Google Scholar 

  21. Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, et al. Uterine selection of human embryos at implantation. Sci Rep. 2014;4:3894.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, Aojanepong T, et al. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One. 2010;5:e10258.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Wintner EM, Hershko-Klement A, Tzadikevitch K, Ghetler Y, Gonen O, Wintner O, et al. Does the transfer of a poor quality embryo together with a good quality embryo affect the In Vitro Fertilization (IVF) outcome? J Ovarian Res. 2017;10:2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2010;93:437–41.

    Article  PubMed  Google Scholar 

  25. Kitaya K, Tada Y, Taguchi S, Funabiki M, Hayashi T, Nakamura Y. Local mononuclear cell infiltrates in infertile patients with endometrial macropolyps versus micropolyps. Hum Reprod. 2012;27:3474–80.

    Article  PubMed  CAS  Google Scholar 

  26. Kitaya K, Matsubayashi H, Yamaguchi K, Nishiyama R, Takaya Y, Ishikawa T, et al. Chronic endometritis: potential cause of infertility and obstetric and neonatal complications. Am J Reprod Immunol. 2016;75:13–22.

    Article  PubMed  Google Scholar 

  27. Yanaihara A, Yorimitsu T, Motoyama H, Iwasaki S, Kawamura T. Location of endometrial polyp and pregnancy rate in infertility patients. Fertil Steril. 2008;90:180–2.

    Article  PubMed  Google Scholar 

  28. Tanimura S, Funamoto H, Hosono T, Shitano Y, Nakashima M, Ametani Y, et al. New diagnostic criteria and operative strategy for cesarean scar syndrome: endoscopic repair for secondary infertility caused by cesarean scar defect. J Obstet Gynaecol Res. 2015;41:1363–9.

    Article  PubMed  Google Scholar 

  29. Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014;35:851–905.

    Article  PubMed  CAS  Google Scholar 

  30. Szekeres-Bartho J, Balasch J. Progestagen therapy for recurrent miscarriage. Hum Reprod Update. 2008;14:27–35.

    Article  PubMed  CAS  Google Scholar 

  31. Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril. 2010;94:2030–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003;79:1317–22.

    Article  PubMed  Google Scholar 

  33. Nastri CO, Lensen SF, Gibreel A, Raine-Fenning N, Ferriani RA, Bhattacharya S, et al. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2015;7:CD009517.

    Google Scholar 

  34. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28:14–38.

    Article  PubMed  CAS  Google Scholar 

  35. Aleyasin A, Abediasl Z, Nazari A, Sheikh M. Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial. Reproduction. 2016;151:637–42.

    Article  PubMed  CAS  Google Scholar 

  36. Navali N, Gassemzadeh A, Farzadi L, Abdollahi S, Nouri M, Hamdi K, et al. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial. Hum Reprod. 2016;31:2520–6.

    Article  PubMed  CAS  Google Scholar 

  37. Santamaria X, Cabanillas S, Cervello I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31:1087–96.

    Article  PubMed  CAS  Google Scholar 

  38. Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, et al. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. 2013;99:156–62.

    Article  PubMed  Google Scholar 

  39. Berger S, Bleich M, Schmid W, Cole TJ, Peters J, Watanabe H, et al. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci U S A. 1998;95:9424–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol. 2002;48:77–86.

    Article  PubMed  Google Scholar 

  41. Nakagawa K, Kwak-Kim J, Ota K, Kuroda K, Hisano M, Sugiyama R, et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood Th1/Th2 cell ratios. Am J Reprod Immunol. 2015;73:353–61.

    Article  PubMed  CAS  Google Scholar 

  42. Nakagawa K, Kuroda K, Sugiyama R, Yamaguchi K. After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby. Reprod Med Biol. 2017;16:297–301.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira((R))) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. 2009;61:113–20.

    Article  PubMed  CAS  Google Scholar 

  44. Chambers CD, Johnson DL. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Res A Clin Mol Teratol. 2012;94:607–11.

    Article  PubMed  CAS  Google Scholar 

  45. Ostensen M, Forger F. How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol. 2013;13:470–5.

    Article  PubMed  CAS  Google Scholar 

  46. Brannstrom M, Johannesson L, Bokstrom H, Kvarnstrom N, Molne J, Dahm-Kahler P, et al. Livebirth after uterus transplantation. Lancet. 2015;385:607–16.

    Article  PubMed  Google Scholar 

  47. Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod. 2011;26:1971–80.

    Article  PubMed  CAS  Google Scholar 

  48. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev. 2007;6:CD005996.

    Google Scholar 

  49. Mirzakhani H, Litonjua AA, McElrath TF, O'Connor G, Lee-Parritz A, Iverson R, et al. Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest. 2016;126:4702–15.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Rudick BJ, Ingles SA, Chung K, Stanczyk FZ, Paulson RJ, Bendikson KA. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil Steril. 2014;101:447–52.

    Article  PubMed  CAS  Google Scholar 

  51. Fabris A, Pacheco A, Cruz M, Puente JM, Fatemi H, Garcia-Velasco JA. Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril. 2014;102:1608–12.

    Article  PubMed  CAS  Google Scholar 

  52. Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A. 2004;101:15178–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Schisterman EF, Silver RM, Lesher LL, Faraggi D, Wactawski-Wende J, Townsend JM, et al. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet. 2014;384:29–36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Mumford SL, Silver RM, Sjaarda LA, Wactawski-Wende J, Townsend JM, Lynch AM, et al. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss. Hum Reprod. 2016;31:657–65.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril. 2003;80:376–83.

    Article  PubMed  Google Scholar 

  56. Colicchia M, Campagnolo L, Baldini E, Ulisse S, Valensise H, Moretti C. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update. 2014;20:884–904.

    Article  PubMed  CAS  Google Scholar 

  57. Vissenberg R, Manders VD, Mastenbroek S, Fliers E, Afink GB, Ris-Stalpers C, et al. Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction. Hum Reprod Update. 2015;21:378–87.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiji Kuroda .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kuroda, K., Ochiai, A. (2018). Unexplained Infertility: Treatment Strategy for Unexplained Infertility. In: Kuroda, K., Brosens, J., Quenby, S., Takeda, S. (eds) Treatment Strategy for Unexplained Infertility and Recurrent Miscarriage. Springer, Singapore. https://doi.org/10.1007/978-981-10-8690-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8690-8_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8689-2

  • Online ISBN: 978-981-10-8690-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation